We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

147 hedge funds and large institutions have $1.58B invested in SpringWorks Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

13% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 48

4% more funds holding

Funds holding: 142 → 147 (+5)

1.96% less ownership

Funds ownership: 111.38% → 109.42% (-2%)

13% less capital invested

Capital invested by funds: $1.82B → $1.58B (-$242M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

43% less call options, than puts

Call options by funds: $256K | Put options by funds: $453K

Holders
147
Holders Change
+5
Holders Change %
+3.52%
% of All Funds
2.33%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
54
Reduced
48
Closed
11
Calls
$256K
Puts
$453K
Net Calls
-$197K
Net Calls Change
+$47K

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$17.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.88M
3
Morgan Stanley
Morgan Stanley
New York
+$5.12M
4
IC
Ikarian Capital
Texas
+$4.88M
5
BlackRock
BlackRock
New York
+$4.55M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$29.6M
2
State Street
State Street
Massachusetts
-$16M
3
ITP
Iron Triangle Partners
Connecticut
-$8.61M
4
Goldman Sachs
Goldman Sachs
New York
-$8.59M
5
O
OrbiMed
New York
-$5.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$12.4M -$24.3K -889 -0.2%
Morgan Stanley
27
Morgan Stanley
New York
$12.2M +$5.12M +187,088 +55%
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$12.2M +$1.71M +62,462 +13%
Northern Trust
29
Northern Trust
Illinois
$12.1M +$551K +20,154 +4%
Charles Schwab
30
Charles Schwab
California
$9.8M +$1.62M +59,138 +16%
Massachusetts Financial Services
31
Massachusetts Financial Services
Massachusetts
$9.42M -$1.91M -69,936 -15%
LCM
32
Laurion Capital Management
New York
$8.59M -$204K -7,469 -2%
SFM
33
Sphera Funds Management
Israel
$7.4M +$199K +7,286 +2%
Norges Bank
34
Norges Bank
Norway
$6.19M – – –
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$5.77M +$9.19K +336 +0.1%
Bessemer Group
36
Bessemer Group
New Jersey
$5.58M – – –
Ameriprise
37
Ameriprise
Minnesota
$5.2M +$42.2K +1,544 +0.7%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$5.03M -$73.2K -2,678 -1%
MCM
39
M28 Capital Management
Connecticut
$4.57M – – –
WP
40
Woodline Partners
California
$4.42M +$1.21M +44,373 +30%
Rafferty Asset Management
41
Rafferty Asset Management
New York
$4.15M -$1.67M -61,227 -25%
IC
42
Ikarian Capital
Texas
$4.12M +$4.88M +178,360 New
PCM
43
Peregrine Capital Management
Minnesota
$3.69M -$274K -10,015 -6%
CS
44
Candriam SCA
Luxembourg
$3.48M – – –
ITP
45
Iron Triangle Partners
Connecticut
$3.47M -$8.61M -314,724 -68%
N
46
Nuveen
North Carolina
$3.45M +$58.8K +2,150 +1%
Walleye Capital
47
Walleye Capital
New York
$3.34M +$2.62M +95,694 +197%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$3.21M +$2.09M +76,316 +122%
Wells Fargo
49
Wells Fargo
California
$3M -$634K -23,175 -15%
TC
50
TwinBeech Capital
New York
$2.83M +$3.35M +122,429 New
1
2
3 4 5

SWTX Hedge Fund Activity: Q3 2023 in Review

147 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2023, worth a combined $1.58B — down 13% from $1.82B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SWTX positions and 11 closed out — a net gain of 6 holders — while 54 added to existing stakes and 48 trimmed.

The largest buyer was Maverick Capital, opening a new position worth an estimated $17.4M. The largest seller was Bank of America, cutting an estimated $29.6M.

  • 147 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2023, up from 142 in Q2 2023.
  • Funds reported $1.58B of SpringWorks Therapeutics stock for Q3 2023, down 13% quarter-over-quarter.
  • 17 funds opened new SpringWorks Therapeutics positions in Q3 2023 and 11 closed out, a net change of +6 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2023 was Maverick Capital, an estimated $17.4M added.
  • The largest SpringWorks Therapeutics seller in Q3 2023 was Bank of America, an estimated $29.6M sold.

Based on aggregated 13F filings for Q3 2023.